Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Citi
Harvard Business School
Covington
AstraZeneca

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 6,644,320

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,644,320
Title: Treatment of hepatitis C using hyperthermia
Abstract:The invention provides a method of treating a patient infected with hepatitis C virus (HCV) comprising raising the core temperature of the patient and then returning the core temperature of the patient to normal at least one time, wherein the core temperature is raised to a temperature range and a duration sufficient to reduce or eliminate the patient\'s viral load of HCV.
Inventor(s): Groth; Karl Emil (St. Paul, MN), Kelly; Theodore Charles (Minnetonka, MN), Westerbeck; Todd L. (Burnsville, MN), Blick; Gary (Stamford, CT)
Assignee: First Circle Medical, Inc. (Minneapolis, MN)
Application Number:09/951,830
Patent Claims:see list of patent claims

Details for Patent 6,644,320

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up First Circle Medical, Inc. (Minneapolis, MN) 2036-04-30 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up First Circle Medical, Inc. (Minneapolis, MN) 2036-04-30 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up First Circle Medical, Inc. (Minneapolis, MN) 2036-04-30 RX search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Sign Up First Circle Medical, Inc. (Minneapolis, MN) 2036-04-30 RX search
Serono Inc REBIF interferon beta-1a SYRINGE 103780 001 2002-03-07 ➤ Sign Up First Circle Medical, Inc. (Minneapolis, MN) 2036-04-30 RX search
Serono Inc REBIF interferon beta-1a SYRINGE 103780 002 2002-03-07 ➤ Sign Up First Circle Medical, Inc. (Minneapolis, MN) 2036-04-30 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Colorcon
Queensland Health
Cantor Fitzgerald
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.